Literature DB >> 29313083

[Neuroendocrine neoplasms of the head and neck].

B Konukiewitz1, A Agaimy2, W Weichert3, G Klöppel3.   

Abstract

Common to all neuroendocrine neoplasms (NENs), irrespective of their site of origin, is the expression of synaptophysin and chromogranin A. NENs of the head and neck region derive either from epithelial or neural/neuroectodermal tissues. The epithelial-type NENs express cytokeratins and include the well-differentiated typical and atypical carcinoids (also called low- and intermediate-grade neuroendocrine carcinomas by WHO), the poorly differentiated high-grade neuroendocrine carcinomas of small and large cell type and the mixed neuroendocrine-nonneuroendocrine neoplasms. The neural-neuroectodermal-type NENs comprise olfactory neuroblastoma and paraganglioma, each of them with distinct clinicopathological characteristics. Olfactory neuroblastomas show a spectrum of histologic differentiation and are prognostically classified by Hyams grading. Paragangliomas often occur multiple and show a familial background. Most head and neck NENs occur in the upper respiratory system. Their diagnosis follows the general guidelines for NENs, focusing on immunohistochemical profiling. Molecular examinations are so far only required in individual cases.

Entities:  

Keywords:  Carcinoid; Neuroendocrine carcinoma; Neuroendocrine tumor; Olfactory neuroblastoma; Paraganglioma

Mesh:

Substances:

Year:  2018        PMID: 29313083     DOI: 10.1007/s00292-017-0404-8

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  22 in total

1.  Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors.

Authors:  Shinichi Yachida; Efsevia Vakiani; Catherine M White; Yi Zhong; Tyler Saunders; Richard Morgan; Roeland F de Wilde; Anirban Maitra; Jessica Hicks; Angelo M Demarzo; Chanjuan Shi; Rajni Sharma; Daniel Laheru; Barish H Edil; Christopher L Wolfgang; Richard D Schulick; Ralph H Hruban; Laura H Tang; David S Klimstra; Christine A Iacobuzio-Donahue
Journal:  Am J Surg Pathol       Date:  2012-02       Impact factor: 6.394

2.  Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart.

Authors:  William D Travis; Elisabeth Brambilla; Allen P Burke; Alexander Marx; Andrew G Nicholson
Journal:  J Thorac Oncol       Date:  2015-09       Impact factor: 15.609

3.  The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms.

Authors:  Olca Basturk; Zhaohai Yang; Laura H Tang; Ralph H Hruban; Volkan Adsay; Chad M McCall; Alyssa M Krasinskas; Kee-Taek Jang; Wendy L Frankel; Serdar Balci; Carlie Sigel; David S Klimstra
Journal:  Am J Surg Pathol       Date:  2015-05       Impact factor: 6.394

Review 4.  Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms.

Authors:  Günter Klöppel
Journal:  Endocr Relat Cancer       Date:  2011-10-17       Impact factor: 5.678

Review 5.  Neuroendocrine neoplasms of the sinonasal region.

Authors:  Diana Bell; Ehab Y Hanna; Randal S Weber; Franco DeMonte; Asterios Triantafyllou; James S Lewis; Antonio Cardesa; Pieter J Slootweg; Göran Stenman; Douglas R Gnepp; Kenneth O Devaney; Juan P Rodrigo; Alessandra Rinaldo; Bruce M Wenig; William H Westra; Justin A Bishop; Henrik Hellquist; Jennifer L Hunt; Kimihide Kusafuka; Bayardo Perez-Ordoñez; Michelle D Williams; Robert P Takes; Alfio Ferlito
Journal:  Head Neck       Date:  2015-07-18       Impact factor: 3.147

6.  Hormonally defined pancreatic and duodenal neuroendocrine tumors differ in their transcription factor signatures: expression of ISL1, PDX1, NGN3, and CDX2.

Authors:  Gratiana Hermann; Björn Konukiewitz; Anja Schmitt; Aurel Perren; Günter Klöppel
Journal:  Virchows Arch       Date:  2011-07-08       Impact factor: 4.064

7.  Somatostatin receptor expression related to TP53 and RB1 alterations in pancreatic and extrapancreatic neuroendocrine neoplasms with a Ki67-index above 20.

Authors:  Björn Konukiewitz; Anna Melissa Schlitter; Moritz Jesinghaus; Dominik Pfister; Katja Steiger; Angela Segler; Abbas Agaimy; Bence Sipos; Giuseppe Zamboni; Wilko Weichert; Irene Esposito; Nicole Pfarr; Günter Klöppel
Journal:  Mod Pathol       Date:  2017-01-06       Impact factor: 7.842

8.  ISL1 expression is not restricted to pancreatic well-differentiated neuroendocrine neoplasms, but is also commonly found in well and poorly differentiated neuroendocrine neoplasms of extrapancreatic origin.

Authors:  Abbas Agaimy; Katharina Erlenbach-Wünsch; Björn Konukiewitz; Anja M Schmitt; Ralf J Rieker; Michael Vieth; Franklin Kiesewetter; Arndt Hartmann; Giuseppe Zamboni; Aurel Perren; Günter Klöppel
Journal:  Mod Pathol       Date:  2013-03-15       Impact factor: 7.842

9.  A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.

Authors:  Laura H Tang; Olca Basturk; Jillian J Sue; David S Klimstra
Journal:  Am J Surg Pathol       Date:  2016-09       Impact factor: 6.394

Review 10.  15 YEARS OF PARAGANGLIOMA: Clinical manifestations of paraganglioma syndromes types 1-5.

Authors:  Diana E Benn; Bruce G Robinson; Roderick J Clifton-Bligh
Journal:  Endocr Relat Cancer       Date:  2015-08       Impact factor: 5.678

View more
  3 in total

Review 1.  [Sinonasal tumors : News from the WHO with special reference to mesenchymal entities].

Authors:  A Agaimy; F Haller; A Hartmann
Journal:  Pathologe       Date:  2018-02       Impact factor: 1.011

Review 2.  Rare Diseases of the Nose, the Paranasal Sinuses, and the Anterior Skull Base.

Authors:  Fabian Sommer
Journal:  Laryngorhinootologie       Date:  2021-04-30       Impact factor: 1.057

Review 3.  Small Cell Neuroendocrine of the Head and Neck: A Rare Presentation and Review of the Literature.

Authors:  Stephanie Niforatos; Michael Sandhu; Mansi Kallem; Serenella Serinelli; Christopher Curtiss; Komal Akhtar
Journal:  J Investig Med High Impact Case Rep       Date:  2022 Jan-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.